Akèy › Kansè tete negatif triple › New York › Syracuse
Etid klinik pou Kansè tete negatif triple nan Syracuse, NY
3 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Syracuse (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Ap rekriteFaz 3
- SUNY Upstate Medical University, Syracuse
- Hematology Oncology Associates of Central New York, PC, East Syracuse · 4 mi lwen
A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)
Ap rekriteFaz 2
- SUNY Upstate Medical University, Syracuse
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Ap rekriteFaz 2/3
- Local Institution - 1037, Syracuse
Etid Kansè tete negatif triple nan lòt vil
- Houston, TX42 etid
- New York City, NY31 etid
- Nashville, TN28 etid
- Los Angeles, CA27 etid
- Boston, MA26 etid
- San Antonio, TX23 etid
- St. Louis, MO21 etid
- Arlington, VA20 etid
- Atlanta, GA20 etid
- Dallas, TX18 etid
- Chicago, IL16 etid
- Columbus, OH16 etid
Lòt etid nan Syracuse
- Kansè Poumon ki pa ti selil15 etid
- Kansè (tout kalite)9 etid
- Kansè pwostat9 etid
- Kansè Vezik ki pa envazif miskilè8 etid
- Kansè ovè7 etid
- Kansè Endomèt7 etid
- Obèsite6 etid
- Kansè poumon6 etid
- Kansè kolorektal5 etid
- Degeneresans makile5 etid
- Leksemi mieloïd egi5 etid
- Dyabèt Tip 25 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.